Biology subjects

Lorenzi, M.

Publications and source records attributed to Lorenzi, M..

5 recordsLinked to original sources

bioRxiv2026

Open neuroinformatics infrastructure ecosystem for federated multisite studies

Despite growing understanding of the benefits of having Findable, Accessible, Interoperable, and Reusable (FAIR) data, many datasets still cannot be shared. Federated analysis methods can enable multisite studies that do not require the sharing of participant-level information. However, there are many practical hurdles that prevent the large-scale adoption of federated methods. We discuss challenges related to cross-site data preparation for federated learning, present solutions offered by recent neuroinformatics projects, and showcase an example of tool integration applied to neurodegenerative disease data.

neuroscience↗

bioRxiv2024

A cautionary tale on the cost-effectiveness of collaborative AI in real-world medical applications.

Federated learning (FL) has gained wide popularity as a collaborative learning paradigm enabling trustworthy AI in sensitive healthcare applications. Never-theless, the practical implementation of FL presents technical and organizational challenges, as it generally requires complex communication infrastructures. In this context, consensus-based learning (CBL) may represent a promising collaborative learning alternative, thanks to the ability of combining local knowledge into a federated decision system, while potentially reducing deployment over-head. In this work we propose an extensive benchmark of the accuracy and cost-effectiveness of a panel of FL and CBL methods in a wide range of collaborative medical data analysis scenarios. Our results reveal that CBL is a cost-effective alternative to FL, providing comparable accuracy and significantly reducing training and communication costs. This study opens a novel perspective on the deployment of collaborative AI in real-world applications, whereas the adoption of cost-effective methods is instrumental to achieve sustainability and democratisation of AI by alleviating the need for extensive computational resources.

bioinformatics↗

bioRxiv2023

Fed-ComBat: A Generalized Federated Framework for Batch Effect Harmonization in Collaborative Studies

The use of multi-centric analyses is crucial for obtaining sufficient sample sizes and representative clinical populations in experimental studies. In this setting, data harmonization techniques are typically employed to address systematic biases and ensure the interoperability of the data. State-of-the-art harmonisation approaches are based on the statistical theory of random effect modeling, allowing to account for either linear of non-linear biases and batch effects. However, optimizing these statistical methods generally requires data centralization at some point during the analysis pipeline, therefore introducing the risk of exposing individual patient information while posing significant data governance issues. To overcome this challenge, in this paper we present Fed-ComBat, a federated framework for batch effect harmonization on decentralized data. Fed-ComBat enables the preservation of nonlinear covariate effects without requiring centralization of data and without prior parametric hypothesis on the variables to account for. We demonstrate the effectiveness of Fed-ComBat against a comprehensive panel of existing approaches based on the state-of-the-art ComBat, along with distributed and nonlinear variants. Our experiments are based on extensive simulated data, and on the analysis of multiple cohorts based on 7 neuroimaging studies comprising healthy controls (CI) and subjects with various disorders such as Parkinsons disease (PD), Alzheimers disease (AD), and autism spectrum disorder (ASD). Our results show that in a federated settings, Fed-ComBat harmonization exhibits comparable results to centralized methods for both linear and nonlinear cases. On real data, harmonized trajectories of the thickness of the right hippocampus across lifespan measured on a set of 7 public studies show comparable results between centralized and federated models and are consistent with the literature when using a nonlinear model. The code is publicly available at: https://gitlab.inria.fr/greguig/fedcombat

neuroscience↗

bioRxiv2020

Simulating the outcome of amyloid treatments in Alzheimer's Disease from multi-modal imaging and clinical data

In this study we investigate a novel quantitative instrument for the development of intervention strategies for disease modifying drugs in Alzheimers disease. Our framework is based on the modeling of the spatio-temporal dynamics governing the joint evolution of imaging and clinical biomarkers along the history of the disease, and allows the simulation of the effect of intervention time and drug dosage on the biomarkers progression. When applied to multi-modal imaging and clinical data from the Alzheimers Disease Neuroimaging Initiative our method enables to generate hypothetical scenarios of amyloid lowering interventions. The results quantify the crucial role of intervention time, and provide a theoretical justification for testing amyloid modifying drugs in the pre-clinical stage. Our experimental simulations are compatible with the outcomes observed in past clinical trials, and suggest that anti-amyloid treatments should be administered at least 7 years earlier than what is currently being done in order to obtain statistically powered improvement of clinical endpoints.

bioinformatics↗

bioRxiv2018

Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: applied to GENFI study

Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used to track neurodegenerative disease progression. In diseases such as frontotemporal dementia or Alzheimers disease, atrophy can be observed in key brain structures years before any clinical symptoms are present. Atrophy is most commonly captured as volume change of key structures and the shape changes of these structures are typically not analysed despite being potentially more sensitive than summary volume statistics over the entire structure.\n\nIn this paper we propose a spatiotemporal analysis pipeline based Large Diffeomorphic Deformation Metric Mapping (LDDMM) to detect shape changes from volumetric MRI scans. We applied our framework to a cohort of individuals with genetic variants of frontotemporal dementia and healthy controls from the Genetic FTD Initiative (GENFI) study. Our method, take full advantage of the LDDMM framework, and relies on the creation of a population specific average spatiotemporal trajectory of a relevant brain structure of interest, the thalamus in our case. The residuals from each patient data to the average spatiotemporal trajectory are then clustered and studied to assess when presymptomatic mutation carriers differ from healthy control subjects.\n\nWe found statistical differences in shape in the anterior region of the thalamus at least five years before the mutation carrier subjects develop any clinical symptoms. This region of the thalamus has been shown to be predominantly connected to the frontal lobe, consistent with the pattern of cortical atrophy seen in the disease.

neuroscience↗